Skip to main content
. Author manuscript; available in PMC: 2017 Jul 10.
Published in final edited form as: Cancer Cell. 2016 Jan 21;29(2):229–240. doi: 10.1016/j.ccell.2015.12.012

Table 3.

Mutation Frequencies of Significantly Mutated Genes in Intestinal-type Ampullary Carcinomas versus Colorectal Carcinomas and Pancreatobiliary-type Carcinomas versus Pancreatic Carcinomas

Intestinal-type ampullary carcinomas Colorectal carcinomas (TCGA) Pancreatobiliary-type ampullary carcinomas Pancreatic carcinomas (Biankin et al., 2012)
1 APC (50%) APC (81%) KRAS (68%) KRAS (99%)
2 TP53 (46%) TP53 (60%) TP53 (67%) TP53 (33%)
3 KRAS (39%) KRAS (43%) SMAD4 (20%) SMAD4 (16%)
4 CTNNB1 (26%) TTN (31%) CTNNB1 (15%) MLL3 (7%)
5 ARID2 (18%) PIK3CA (18%) ERBB3 (14%) ATM (5%)
6 ERBB2 (14%) FBXW7 (11%) GNAS (12%) NALCN (5%)
7 ACVR2A (13%) SMAD4 (10%) CDH10 (12%) ARID1A (4%)
8 SMAD4 (13%) NRAS (9%) ELF3 (11%) SF3B1 (4%)
9 GNAS (13%) TCF7L2 (9%) CDKN2A (9%) TGFBR2 (4%)
10 SOX9 (13%) FAM123B (7%) ARID2 (3%)